186 related articles for article (PubMed ID: 26315454)
1. Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands.
Timmermans AJ; van Dijk BA; Overbeek LI; van Velthuysen ML; van Tinteren H; Hilgers FJ; van den Brekel MW
Head Neck; 2016 Apr; 38 Suppl 1():E1247-55. PubMed ID: 26315454
[TBL] [Abstract][Full Text] [Related]
2. T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol.
Timmermans AJ; de Gooijer CJ; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Head Neck; 2015 Oct; 37(10):1495-503. PubMed ID: 24891221
[TBL] [Abstract][Full Text] [Related]
3. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.
Vengalil S; Giuliani ME; Huang SH; McNiven A; Song Y; Xu W; Chan B; Hope A; Cho J; Bayley A; Ringash J; Goldstein D; Razak A; Irish J; Gilbert R; Gullane P; Waldron J; Kim J; O'Sullivan B
Head Neck; 2016 Apr; 38 Suppl 1():E2035-40. PubMed ID: 26828197
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
6. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
7. Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.
Nobacht A; Meijer TWH; Oosting SF; van der Vegt B; Wedman J; Halmos GB; Plaat BEC
J Laryngol Otol; 2024 Jun; 138(6):672-678. PubMed ID: 38235588
[TBL] [Abstract][Full Text] [Related]
8. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
[TBL] [Abstract][Full Text] [Related]
9. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
Chen AY; Fedewa S; Zhu J
Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
[TBL] [Abstract][Full Text] [Related]
10. Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer.
Hsin LJ; Fang TJ; Tsang NM; Chin SC; Yen TC; Li HY; Liao CT; Chen IH
Laryngoscope; 2014 May; 124(5):1134-40. PubMed ID: 24127228
[TBL] [Abstract][Full Text] [Related]
11. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
[TBL] [Abstract][Full Text] [Related]
12. Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands.
Petersen JF; Timmermans AJ; van Dijk BAC; Overbeek LIH; Smit LA; Hilgers FJM; Stuiver MM; van den Brekel MWM
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):181-189. PubMed ID: 29080963
[TBL] [Abstract][Full Text] [Related]
13. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
Dyckhoff G; Plinkert PK; Ramroth H
BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
[TBL] [Abstract][Full Text] [Related]
14. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
15. Curative-dose Chemoradiotherapy Versus Total Laryngectomy For Stage T3-T4 Squamous Cell Carcinoma of the Larynx: An "Apples-to-Apples" Analysis of the National Cancer Database.
Bates JE; Amdur RJ; Morris CM; Hitchcock KE; Dziegielewski PT; Boyce BJ; Silver NL; Shaw C; Mendenhall WM
Am J Clin Oncol; 2019 Jun; 42(6):527-533. PubMed ID: 31136370
[TBL] [Abstract][Full Text] [Related]
16. Tumor volume as a prognostic factor for local control and overall survival in advanced larynx cancer.
Timmermans AJ; Lange CA; de Bois JA; van Werkhoven E; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Laryngoscope; 2016 Feb; 126(2):E60-7. PubMed ID: 26333005
[TBL] [Abstract][Full Text] [Related]
17. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
18. Time trends in T3 to T4 laryngeal cancer: a population-based long-term analysis.
Reizenstein JA; Holmberg L; Bergqvist M; Linder A; Ekman S; Lödén B; Holmqvist M; Hellström K; von Beckerath M; Blomquist E; Bergström SN
Head Neck; 2014 Dec; 36(12):1727-31. PubMed ID: 24166872
[TBL] [Abstract][Full Text] [Related]
19. Treatment, comorbidity and survival in stage III laryngeal cancer.
Connor KL; Pattle S; Kerr GR; Junor E
Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
[TBL] [Abstract][Full Text] [Related]
20. Modifications in the treatment of advanced laryngeal cancer throughout the last 30 years.
García Lorenzo J; Montoro Martínez V; Rigo Quera A; Codina Aroca A; López Vilas M; Quer Agustí M; León Vintró X
Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3449-3455. PubMed ID: 28625009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
